IP Library › Granted Patent US 8,609,426
Granted Patent B2
US 8,609,426 · App. 13/359,313 · Granted Dec 17, 2013

Sensors for detecting substances indicative of stroke, ischemia, infection or inflammation

Inventor: James H Silver (Palo Alto, CA)
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,609,426
App. No.
13/359,313
Granted
Dec 17, 2013
Kind
B2
Abstract

A system is disclosed that extracts bodily fluid to a reaction chamber for monitoring a substance or property of the patient fluid. In one embodiment, a pump is used to advance the sample of bodily fluid through a filter to produce a filtrate. Another pump advances filtrate into the reaction chamber, while another pump advances reactant into the reaction chamber. A sensor in communication with the reaction chamber determines a concentration of nitric oxide or one of its metabolic products. Methods are also disclosed.

Claims (22)

1. A method of assessing vascular status in a patient, the method comprising:

positioning a sensor in communication with a body fluid;

measuring, using the sensor, a concentration of a nitric oxide metabolite in the body fluid;

determining, in a processor, a baseline concentration of the nitric oxide metabolite in the body fluid, based on the measured concentration;

monitoring changes in the concentration of the nitric oxide metabolite in the body fluid from the baseline concentration, wherein the changes are indicative of the vascular status; and

activating a signal in response to a change in the concentration of the nitric oxide metabolite from the baseline concentration by more than a predetermined limit.

2. A method as in claim 1 , wherein positioning the sensor comprises positioning the sensor in communication with blood.

3. A method as in claim 1 , wherein positioning the sensor comprises positioning the sensor in communication with cerebrospinal fluid.

4. A method as in claim 1 , wherein the nitric oxide metabolite comprises an indicator of a presence of nitric oxide in the body fluid, and wherein the metabolite is selected from the group consisting of nitrite and nitrate.

5. A method as in claim 1 , wherein activating the signal comprises activating an alarm.

6. A method as in claim 5 , wherein activating the alarm comprises activating an alarm selected from the group consisting of an audio alarm, a visual alarm, a tactile feedback alarm and a transmission of information to a remote location.

7. A method as in claim 1 , wherein activating the signal comprises activating application of a responsive therapy to the patient.

8. A method as in claim 1 , wherein the signal is activated when the change from the baseline concentration is between about 0.01% and about 100% per second.

9. A method as in claim 1 , wherein the signal is activated when the change from the baseline concentration is more than about 10% to about 100,000%.

10. A method of assessing vascular status in a patient, the method comprising:

positioning a sensor in communication with a body fluid;

measuring, using the sensor, a concentration of a nitric oxide metabolite in the body fluid;

determining, in a processor, a range of acceptable concentrations of the nitric oxide metabolite in the body fluid, based on the measured concentration;

monitoring changes in the concentration of the nitric oxide metabolite in the body fluid from the measured concentration, wherein the changes are indicative of the vascular status; and

activating a signal in response to a measurement of the concentration of the nitric oxide metabolite that is outside the range of acceptable concentrations.

11. A method as in claim 10 , wherein positioning the sensor comprises positioning the sensor in communication with blood.

12. A method as in claim 10 , wherein positioning the sensor comprises positioning the sensor in communication with cerebrospinal fluid.

Continuity (3)
Continuation 12015347 · Jan 16, 2008
Continuation In Part 11280680 · Nov 16, 2005
Related Publication 20120135531A1 · May 31, 2012